Mostafa Mousa

Mostafa Mousa has extensive experience in the pharmaceutical industry, with significant roles at Roche as an Oncology Product Specialist and Medical Science Liaison from December 2016 to December 2018, and at Pfizer from December 2015 to October 2016 as a Product Specialist in immunology. Notably, during the time at Pfizer, responsibilities included launching and promoting Xeljanz across western and southern regions of Saudi Arabia, along with cultivating customer loyalty and driving growth in the biologics market. Prior experience also includes positions at Novartis, where as a Senior Medical Manager, sales growth and market share were significantly increased in the ARBs market. Mostafa Mousa holds a Master of Science in Public Health from the London School of Hygiene and Tropical Medicine and degrees in Clinical Pharmacy from Tanta University, as well as completing HMX fundamentals programs in Immunology and Medical Genetics at Harvard Medical School.